梅花集团官网—专注生物科技,创享美好未来 Inosine-Meihua Group-Focusing on Biotechnology, Building and Sharing Better Future

Inosine

澳门黄金城官网赌城.jpg

It is applicable to leucopenia and thrombocytopenia caused by various kinds of reasons, various kinds of heart disease, acute and chronic hepatitis and liver cirrhosis, and also can be used to cure central serous chorioretinopathy, optic atrophy, etc.

 

Basic information 


Specific rotation:-49.2° (c=1,H2O 18°C)    water-solubility:2.1 g/100 mL (20°C)   

vapor pressure:1.52E-22mmHg at 25°C


Pharmacologic action


This drug is normal constituents of human body, is the precursor of adenine; it can directly penetrate cell membrane and enter into the somatic cell to participate in the body metabolism of nucleic acid, energy metabolism and synthesis of protein. 

This drug can activate pyruvic oxidase, enhance the activity of coenzyme A, activate liver function and improve the histocyte continue to perform metabolism under low energy and anaerobic condition; it contributes to functional recovery of damaged hepatic cell and participates the body energy metabolism and synthesis of protein.

This drug can increase ATP level and transform into various kinds of nucleotide. It can stimulate the body to generate antibody and also can improve iron absorbing of intestinal tract, activate liver function and accelerate repairing of hepatic cells. It also have function to enhance leukocyte proliferation. 


Indications 


1.It is applicable to leucopenia and thrombocytopenia

2.It is applicable to acute and chronic hepatitis, liver cirrhosis and hepatic encephalopathy.

3.It is used as adjuvant drug for coronary atherosclerotic heart disease (coronary disease), myocardial infarction, rheumatic heart disease and pulmonary heart disease. 

4.It is used to prevent and relieve heart and liver toxic reaction caused by schistosomiasis prevention and cure drugs

5.It is used as adjuvant drug for ophthalmic Diseases (central serous chorioretinopathy, optic atrophy)


Notice


This product has no compatibility with chloramphenicol, dipyridamole, thiopental sodium and orotic acid injection. 

Client inquiry|Webs of subsidiary members|Contact Us|Legal Statement|Privacy Protection

Focusing on Biotechnology, Building and Sharing Better Future

CopyRight @ 2005 MEIHUA HOLDINGS GROUP CO., LTD .

  • WeChat

  • Mobile

Contact Us

MEIHUA HOLDINGS GROUP CO., LTD.

Registered address: Kim Lhasa Tibet autonomous region west road no. 189

Office address: No.66 Huaxiang Road,Economic and Technical Development Area,Langfang City, Hebei Province 065001, China

The service hotline: 400-960-0873

Tel: +86 316-2359999 Fax: +86 316-2359679

Email:meihua@meihuagrp.com

URL:www.meihuagrp.com

友情链接:顶级娱乐场